Tyle Praveen Insider Trades

Insider Trading History

Track insider trading activity for Tyle Praveen. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Director
Holding Value $78.9k 30,000 shares
Last Trade
Apr 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87.9k 30,000 shares
$2.93
$2.63
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Director
Holding Value $13.2k 5,014 shares
Last Trade
Aug 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.8k 5,000 shares
$3.96
$2.63
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Director
Holding Value $4.68k 1,778 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.73k 1,778 shares
$4.35
$2.63
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $27k 35,000 shares
Last Trade
Feb 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$510k 35,000 shares
$14.56
$0.77
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $15.4k 20,001 shares
Last Trade
Nov 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.7k 14,110 shares
$1.75
$0.77
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Director
Holding Value $13.2k 5,000 shares
Last Trade
Sep 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.6k 5,000 shares
$5.11
$2.63
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $1.13M 1,472,692 shares
Last Trade
Aug 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.9k 1,472,692 shares
$0.01
$0.77
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Director
Holding Value $21k 8,000 shares
Last Trade
Mar 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$276k 8,000 shares
$34.47
$2.63
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $193k 250,000 shares
Last Trade
Jan 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.15k 250,000 shares
$0.02
$0.77
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $193k 250,000 shares
Last Trade
Jan 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.15k 250,000 shares
$0.02
$0.77
Kiora Pharmaceuticals
Kiora Pharmaceuticals KPRX
Director
Holding Value $13.2k 5,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.38M 5,000 shares
$275.58
$2.63
AB Active ETFs- AB Corporate Bond ETF
AB Active ETFs- AB Corporate Bond ETF EYEG
Director
Holding Value $176k 5,000 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.75k 5,000 shares
$1.95
$35.20
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $212k 275,000 shares
Last Trade
Sep 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3k 25,000 shares
$0.12
$0.77
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $193k 250,000 shares
Last Trade
Jul 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35k 250,000 shares
$0.14
$0.77
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Evp, R&d
Holding Value $152k 82,061 shares
Last Trade
Feb 28, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$69.9k 9,727 shares
$7.19
$1.85
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Evp, R&d
Holding Value $201k 108,661 shares
Last Trade
Feb 28, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$191k 26,600 shares
$7.19
$1.85
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Evp, R&d
Holding Value $223k 120,791 shares
Last Trade
Feb 28, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$119k 16,560 shares
$7.19
$1.85
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Evp, R&d
Holding Value $254k 137,351 shares
Last Trade
Feb 28, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$206k 28,690 shares
$7.19
$1.85
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Evp, R&d
Holding Value $0 0 shares
Last Trade
Feb 28, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$69.9k 9,727 shares
$7.19
$1.85
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Evp, R&d
Holding Value $49.2k 26,600 shares
Last Trade
Feb 28, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$191k 26,600 shares
$7.19
$1.85

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up